Home ER stress & UPR -Immunology & Inflammation PKR

PKR

PKR Products

  • All (5)
  • PKR Inhibitor (1)
  • PKR Activator (1)
  • New PKR Products
Catalog No. Product Name Information Product Use Citations Product Validations
S9668 PKR-IN-C16 PKR-IN-C16 (imoxin, C16, Imidazolo-oxindole PKR inhibitor C16) is a specific inhibitor of RNA-dependent protein kinase (PKR, Protein Kinase R, EIF2AK2). PKR-IN-C16 prevents apoptosis and IL-1β production in an acute excitotoxic rat model with a neuroinflammatory component.
Exp Mol Med, 2024, 56(2):408-421.
EMBO J, 2024, 43(5):780-805.
Respir Res, 2024, 25(1):201
F1207 PKR Rabbit mAb
F1597New Phospho-PKR (Thr 446) Rabbit mAb
F2996New PACT (PKR activating protein) / PRKRA Rabbit mAb PACT,PACT (PKR activating protein) / PRKRA
E2388 PKR-IN-2 PKR-IN-2 is a pyruvate kinase isoform PKR activator extracted from patent WO2014139144A1, compound 160, which can be used for the research of PKR function related diseases, including cancer, diabetes, obesity, autoimmune disorders, and benign prostatic hyperplasia.
S9668 PKR-IN-C16 PKR-IN-C16 (imoxin, C16, Imidazolo-oxindole PKR inhibitor C16) is a specific inhibitor of RNA-dependent protein kinase (PKR, Protein Kinase R, EIF2AK2). PKR-IN-C16 prevents apoptosis and IL-1β production in an acute excitotoxic rat model with a neuroinflammatory component.
Exp Mol Med, 2024, 56(2):408-421.
EMBO J, 2024, 43(5):780-805.
Respir Res, 2024, 25(1):201
E2388 PKR-IN-2 PKR-IN-2 is a pyruvate kinase isoform PKR activator extracted from patent WO2014139144A1, compound 160, which can be used for the research of PKR function related diseases, including cancer, diabetes, obesity, autoimmune disorders, and benign prostatic hyperplasia.
F1597New Phospho-PKR (Thr 446) Rabbit mAb
F2996New PACT (PKR activating protein) / PRKRA Rabbit mAb PACT,PACT (PKR activating protein) / PRKRA

Choose Selective PKR Inhibitors

Tags: PKR inhibitor|PKR agonist|PKR activator|PKR inducer|PKR antagonist|PKR signaling pathway|PKR assay kit